Global genomic diversity of Pseudomonas aeruginosa in bronchiectasis
Niamh E. HarringtoniD, Anastasia KottaraiD, Kendall CagneyiD, Matthew James ShepherdiD, Elizabeth M. GrimseyiD, Taoran FuiD, Rebecca C HulliD, Dylan Z. ChildsiD, Joanne L. FothergilliD, James Duncan ChalmersiD, Michael A. BrockhurstiD, Steve PatersoniD
Abstract
BackgroundPseudomonas aeruginosa is the dominant pathogen causing lung infections in people with both cystic fibrosis (CF) and bronchiectasis, associated with poorer outcomes. Unlike CF, bronchiectasis has been a neglected disease. More extensive genomic studies of larger bronchiectasis patient cohorts and within patient sampling are needed to improve understanding of the evolutionary mechanisms underpinning P. aeruginosa infections to guide novel and improved treatments. MethodsWe have performed genome sequencing of 2,854 P. aeruginosa isolates from 180 patients attending clinics worldwide to analyse the genomic diversity between and within patient infections. ResultsWe observed high genetic diversity between infections with low incidence of highly transmissible strains. Our genomic data provide evidence for the mutational targets driving P. aeruginosa evolution in bronchiectasis. Some functions found to gain mutations were comparable to CF, including biofilm and iron acquisition, whilst others highlighted distinct evolutionary paths in bronchiectasis such as pyocin production and resistance, and a novel efflux pump gene (PA1874). We also show a high incidence of antimicrobial resistance-associated mutations and acquired resistance genes, in particular multidrug efflux and fluoroquinolone resistance mechanisms. ConclusionsOur findings highlight important differences between P. aeruginosa infections in bronchiectasis and CF and provide evidence of the relatively minor role transmissible strains play in bronchiectasis. Our study provides a 10-fold increase in the available genomic data for these infections and is a global resource to improve our knowledge and understanding, to facilitate better patient outcomes. SummaryThe largest genomic study of Pseudomonas aeruginosa bronchiectasis isolates to-date, providing an unprecedented global genomic resource. We highlight important differences between bronchiectasis and cystic fibrosis, including key genes under selection.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The Role of Hypermutation and Collateral Sensitivity in Antimicrobial Resistance Diversity of Pseudomonas aeruginosa Populations in Cystic Fibrosis Lung Infection
J. Vanderwoude, S. Azimi, … S. P. Diggle·bioRxiv·Jun 14, 2023
- Divergent In vitro MIC Characteristics and underlying isogenic mutations in host-specialized Pseudomonas aeruginosa
Xuan Qin, Alexander L Greninger, … Danielle M. Zerr·bioRxiv·Mar 21, 2017
- Hypermutator Pseudomonas aeruginosa exploits multiple genetic pathways to develop multidrug resistance during long term infections in the airways of cystic fibrosis patients
C. A. Colque, A. Albarracin Orio, … A. M. Smania·bioRxiv·Oct 17, 2019
- Genomics of experimental diversification of Pseudomonas aeruginosa in cystic fibrosis lung-like conditions
- Rapid diversification of Pseudomonas aeruginosa in cystic fibrosis lung-like conditions
- Comparative genomics of clinical isolates of Pseudomonas aeruginosa from cystic fibrosis patients in Mexico
Evelin Martinez, Armando Gerónimo-Gallegos, … Corina Diana Ceapă·bioRxiv·Sep 1, 2026